Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-11 8:00 pm |
N/A 2035-03-07 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
169,000 | $0 | 306,898 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-08 8:00 pm |
N/A 2034-03-07 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-07 8:22 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
44,000 | $0 | 137,898 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-29 8:00 pm |
N/A 2029-12-04 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
40,226 | $0 | 201,762 (Direct) |
View |
| 2023-03-28 Exercise |
2023-03-29 8:00 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
40,226 | $2.95 | 201,762 (Direct) |
View |
| 2023-03-09 Option Award |
2023-03-10 7:52 pm |
N/A 2033-03-09 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 7:58 pm |
N/A 2032-03-11 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-05 7:55 pm |
N/A 2029-12-04 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
53,672 | $0 | 201,762 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-05 7:55 pm |
N/A N/A |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
53,672 | $2.95 | 201,762 (Direct) |
View |
| 2021-06-24 Option Award |
2021-06-25 8:00 pm |
N/A 2031-06-24 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:15 pm |
N/A 2031-03-01 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
72,000 | $0 | 72,000 (Direct) |
View |
Ownership |
2020-07-23 7:21 pm |
N/A 2029-12-04 |
iTeos Therapeutics Inc. | ITOS | Call Matthew Chief Operating Officer |
0 | $0 | 365,671 (Direct) |
View |